MedTrace Logo

Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome

NCT05080803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 608

Last updated 2023-09-28

No results posted yet for this study

Summary

Retrospective multi-center observational study on functional and morphological outcome of initial therapy for DME according to ESASO Morphologic Classification.

Conditions

Interventions

DRUG

intravitreal administration of bevacizumab/ranibizumab/aflibercept/desamethazone

intravitreal administration

Sponsors & Collaborators

  • European School of Advanced Studies in Ophthalmology

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-12-23
Completion
2022-07-26
FDA Drug
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080803 on ClinicalTrials.gov